Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P BERNASCONI

Showing results (301-310 of 314) with videos related to

Pageof 32
Sort By:
Annals of Surgical Oncology|March 23, 2024
Predicting the Risk of Morbidity by GLIM-Based Nutritional Assessment and Body Composition Analysis in Oncologic Abdominal Surgery in the Context of Enhanced Recovery Programs : The PHase Angle Value in Abdominal Surgery (PHAVAS) StudyMarta Sandini, Luca Gianotti, Salvatore Paiella, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC studyA Sartore-Bianchi, F Toscano, D P Bernasconi, et al.
World Journal of Surgery|June 27, 2019
Association Between Compliance to an Enhanced Recovery Protocol and Outcome After Elective Surgery for Gastric Cancer. Results from a Western Population-Based Prospective Multicenter StudyLuca Gianotti, Uberto Fumagalli Romario, Stefano De Pascale, et al.
Neurology|June 3, 2021
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral NeurotoxicityPaola Alberti, Davide P Bernasconi, David R Cornblath, et al.
United European Gastroenterology Journal|October 22, 2025
Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER)A Gerussi, E Nofit, D P Bernasconi, et al.
Leukemia|June 22, 2001
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patientsG Visani, P Bernasconi, M Boni, et al.
Oncogene|May 10, 2016
Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodiesP Bernasconi-Elias, T Hu, D Jenkins, et al.
Annals of Surgery|January 26, 2022
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted ComparisonSimone Famularo, Matteo Donadon, Federica Cipriani, et al.
ESC Heart Failure|February 23, 2026
Colchicine in patients with chronic inflammatory cardiomyopathy: Rationale and design of the CMP-MYTHiCEnrico Ammirati, Iside Cartella, Michele Ciabatti, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 4, 2020
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparisonSimone Famularo, Matteo Donadon, Federica Cipriani, et al.
Pageof 32

Showing results (301-310 of 314) with videos related to

Sort By:
Pageof 32
Annals of Surgical Oncology|March 23, 2024
Predicting the Risk of Morbidity by GLIM-Based Nutritional Assessment and Body Composition Analysis in Oncologic Abdominal Surgery in the Context of Enhanced Recovery Programs : The PHase Angle Value in Abdominal Surgery (PHAVAS) StudyMarta Sandini, Luca Gianotti, Salvatore Paiella, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Patient-Reported Experience Measures (PREMs) in patients with metastatic colorectal cancer undergoing treatment supported by feedback auditing: the EPIC studyA Sartore-Bianchi, F Toscano, D P Bernasconi, et al.
World Journal of Surgery|June 27, 2019
Association Between Compliance to an Enhanced Recovery Protocol and Outcome After Elective Surgery for Gastric Cancer. Results from a Western Population-Based Prospective Multicenter StudyLuca Gianotti, Uberto Fumagalli Romario, Stefano De Pascale, et al.
Neurology|June 3, 2021
Prospective Evaluation of Health Care Provider and Patient Assessments in Chemotherapy-Induced Peripheral NeurotoxicityPaola Alberti, Davide P Bernasconi, David R Cornblath, et al.
United European Gastroenterology Journal|October 22, 2025
Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER)A Gerussi, E Nofit, D P Bernasconi, et al.
Leukemia|June 22, 2001
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patientsG Visani, P Bernasconi, M Boni, et al.
Oncogene|May 10, 2016
Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodiesP Bernasconi-Elias, T Hu, D Jenkins, et al.
Annals of Surgery|January 26, 2022
Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma: A Real-life Multicentric Weighted ComparisonSimone Famularo, Matteo Donadon, Federica Cipriani, et al.
ESC Heart Failure|February 23, 2026
Colchicine in patients with chronic inflammatory cardiomyopathy: Rationale and design of the CMP-MYTHiCEnrico Ammirati, Iside Cartella, Michele Ciabatti, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 4, 2020
Curative versus palliative treatments for recurrent hepatocellular carcinoma: a multicentric weighted comparisonSimone Famularo, Matteo Donadon, Federica Cipriani, et al.
Pageof 32